Blood Vessel Formation

Principles of Developmental Genetics: Second Edition

Volumn , Issue , 2015, Pages 421-449

  Stratman, Amber N ^a   Yu, Jianxin A ^a   Mulligan, Timothy S ^a   Butler, Matthew G ^a   Sause, Eric T ^a   Weinstein, Brant M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Angiogenesis; Arterial venous differentiation; Lymphatic development; Vascular development; Vascular endothelial growth factor (VEGF); Vascular patterning; Vasculogenesis

Indexed keywords

EID: 84943399953     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-405945-0.00024-7     Document Type: Chapter

References (288)

1. Abengozar M.A., de Frutos S., et al. Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood 2012, 119(19):4565-4576.
2. Abtahian F., Guerriero A., et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003, 299(5604):247-251.
3. Adams R.H., Diella F., et al. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 2001, 104(1):57-69.
4. Adams R.H., Eichmann A. Axon guidance molecules in vascular patterning. Cold Spring Harb. Perspect. Biol. 2010, 2(5):a001875.
5. Adams R.H., Wilkinson G.A., et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999, 13(3):295-306.
6. Alders M., Hogan B.M., et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat. Genet. 2009, 41(12):1272-1274.
7. Ambati B.K., Nozaki M., et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature 2006, 443(7114):993-997.
8. Ambler C.A., Nowicki J.L., et al. Assembly of trunk and limb blood vessels involves extensive migration and vasculogenesis of somite-derived angioblasts. Dev. Biol. 2001, 234(2):352-364.
9. Ambler C.A., Schmunk G.M., et al. Stem cell-derived endothelial cells/progenitors migrate and pattern in the embryo using the VEGF signaling pathway. Dev. Biol. 2003, 257(1):205-219.
10. Aranguren X.L., Beerens M., et al. COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1. J. Cell. Sci. 2013, 126(Pt 5):1164-1175.
11. Artavanis-Tsakonas S., Rand M.D., et al. Notch signaling: cell fate control and signal integration in development. Science 1999, 284(5415):770-776.
12. Avraham-Davidi I., Ely Y., et al. ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1. Nat. Med. 2012, 18(6):967-973.
13. Bagri A., Tessier-Lavigne M. Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. Adv. Exp. Med. Biol. 2002, 515:13-31.
14. Barrantes I.B., Elia A.J., et al. Interaction between Notch signaling and Lunatic fringe during somite boundary formation in the mouse. Curr. Biol. 1999, 9(9):470-480.
15. Basile J.R., Barac A., et al. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res. 2004, 64(15):5212-5224.
16. Bedell V.M., Yeo S.Y., et al. roundabout4 is essential for angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 2005, 102(18):6373-6378.
17. Benedito R., Rocha S.F., et al. Notch-dependent VEGFR3 up-regulation allows angiogenesis without VEGF-VEGFR2 signaling. Nature 2012, 484(7392):110-114.
18. Bertozzi C.C., Schmaier A.A., et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood 2010, 116(4):661-670.
19. Bertrand J.Y., Traver D. Hematopoietic cell development in the zebrafish embryo. Curr. Opin. Hematol. 2009, 16(4):243-248.
20. + leukocytes. Dev. Cell. 2010, 18(3):437-449.
21. Bos F.L., Caunt M., et al. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ. Res. 2011, 109(5):486-491.
22. Bouvree K., Brunet I., et al. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ. Res. 2012, 111(4):437-445.
23. Bouvree K., Larrivee B., et al. Netrin-1 inhibits sprouting angiogenesis in developing avian embryos. Dev. Biol. 2008, 318(1):172-183.
24. Bovenkamp D.E., Goishi K., et al. Expression and mapping of duplicate neuropilin-1 and neuropilin-2 genes in developing zebrafish. Gene. Expr. Patterns 2004, 4(4):361-370.
25. Bressan M., Davis P., et al. Notochord-derived BMP antagonists inhibit endothelial cell generation and network formation. Dev. Biol. 2009, 326(1):101-111.
26. Butler M.G., Isogai S., et al. Lymphatic development. Birth Defects Res C Embryo. Today 2009, 87(3):222-231.
27. Carmeliet P., Collen D. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin. Ann. N. Y. Acad. Sci. 2000, 902:249-262. discussion 262-244.
28. Carmeliet P., Conway E.M. Growing better blood vessels. Nat. Biotechnol. 2001, 19(11):1019-1020.
29. Carmeliet P., Ferreira V., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380(6573):435-439.
30. Carramolino L., Fuentes J., et al. Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis. Circ. Res. 2010, 106(7):1197-1201.
31. Cermenati S., Moleri S., et al. Sox18 genetically interacts with VegfC to regulate lymphangiogenesis in zebrafish. Arterioscler. Thromb. Vasc. Biol 2013, 33(6):1238-1247.
32. Cha Y.R., Fujita M., et al. Chemokine signaling directs trunk lymphatic network formation along the pre-existing blood vasculature. Dev. Cell. 2012, 22(4):824-836.
33. Chappell J.C., Taylor S.M., et al. Local guidance of emerging vessel sprouts requires soluble Flt-1. Dev. Cell. 2009, 17(3):377-386.
34. Chen H., Bagri A., et al. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron 2000, 25(1):43-56.
35. Childs S., Chen J.N., et al. Patterning of angiogenesis in the zebrafish embryo. Development 2002, 129(4):973-982.
36. Chitnis A.B. The role of Notch in lateral inhibition and cell fate specification. Mol. Cell. Neurosci. 1995, 6(6):311-321.
37. Choi K. Hemangioblast development and regulation. Biochem. Cell. Biol. 1998, 76(6):947-956.
38. Chung Y.S., Zhang W.J., et al. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development 2002, 129(23):5511-5520.
39. Cleaver O., Krieg P.A. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus. Development 1998, 125(19):3905-3914.
40. Coffin J.D., Poole T.J. Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. Development 1988, 102(4):735-748.
41. Coultas L., Chawengsaksophak K., et al. Endothelial cells and VEGF in vascular development. Nature 2005, 438(7070):937-945.
42. Davis S., Aldrich T.H., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87(7):1161-1169.
43. Davis-Dusenbery B.N., Wu C., et al. Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation. Arterioscler. Thromb. Vasc. Biol. 2011, 31(11):2370-2377.
44. Doetschman T.C., Eistetter H., et al. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 1985, 87:27-45.
45. Donovan J., Kordylewska A., et al. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Curr. Biol. 2002, 12(18):1605-1610.
46. Drake C.J., Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood 2000, 95(5):1671-1679.
47. Duarte A., Hirashima M., et al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004, 18(20):2474-2478.
48. Dumont D.J., Fong G.H., et al. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev. Dyn. 1995, 203(1):80-92.
49. Dumont D.J., Jussila L., et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282(5390):946-949.
50. Eichmann A., Corbel C., et al. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc. Natl. Acad. Sci. USA 1997, 94(10):5141-5146.
51. Eichmann A., Yuan L., et al. Vascular development: from precursor cells to branched arterial and venous networks. Int. J. Dev. Biol. 2005, 49(2-3):259-267.
52. Emerick K.M., Krantz I.D., et al. Intracranial vascular abnormalities in patients with Alagille syndrome. J. Pediatr. Gastroenterol. Nutr. 2005, 41(1):99-107.
53. Fazeli A., Dickinson S.L., et al. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 1997, 386(6627):796-804.
54. Felcht M., Luck R., et al. Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J. Clin. Invest. 2012, 122(6):1991-2005.
55. Ferkowicz M.J., Starr M., et al. CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo. Development 2003, 130(18):4393-4403.
56. Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer 1996, 32A(14):2413-2422.
57. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol. 1999, 237:1-30.
58. Ferrara N., Gerber H.P., et al. The biology of VEGF and its receptors. Nat. Med. 2003, 9(6):669-676.
59. Ferrell R.E., Levinson K.L., et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum. Mol. Genet. 1998, 7(13):2073-2078.
60. Fina L., Molgaard H.V., et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990, 75(12):2417-2426.
61. Finney B.A., Schweighoffer E., et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 2012, 119(7):1747-1756.
62. Fischer A., Leimeister C., et al. Hey bHLH factors in cardiovascular development. Cold. Spring. Harb. Symp. Quant. Biol. 2002, 67:63-70.
63. Fish J.E., Wythe J.D., et al. A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development 2011, 138(7):1409-1419.
64. Fisher A., Caudy M. The function of hairy-related bHLH repressor proteins in cell fate decisions. Bioessays 1998, 20(4):298-306.
65. Flamme I., Frolich T., et al. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J. Cell. Physiol. 1997, 173(2):206-210.
66. Folkman J., D'Amore P.A. Blood vessel formation: what is its molecular basis?. Cell 1996, 87(7):1153-1155.
67. Fong G.H., Rossant J., et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376(6535):66-70.
68. Foo S.S., Turner C.J., et al. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 2006, 124(1):161-173.
69. Fouquet B., Weinstein B.M., et al. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev. Biol. 1997, 183(1):37-48.
70. Francois M., Caprini A., et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008, 456(7222):643-647.
71. Francois M., Short K., et al. Segmental territories along the cardinal veins generate lymph sacs via a ballooning mechanism during embryonic lymphangiogenesis in mice. Dev. Biol. 2012, 364(2):89-98.
72. Fryxell K.J., Soderlund M., et al. An animal model for the molecular genetics of CADASIL. (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). Stroke 2001, 32(1):6-11.
73. Gale N.W., Baluk P., et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev. Biol. 2001, 230(2):151-160.
74. Gale N.W., Dominguez M.G., et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 2004, 101(45):15949-15954.
75. Gale N.W., Thurston G., et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev. Cell. 2002, 3(3):411-423.
76. Gale N.W., Yancopoulos G.D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes. Dev. 1999, 13(9):1055-1066.
77. Gavard J., Patel V., et al. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell. 2008, 14(1):25-36.
78. Gerber H.P., Hillan K.J., et al. VEGF is required for growth and survival in neonatal mice. Development 1999, 126(6):1149-1159.
79. Gerety S.S., Anderson D.J. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 2002, 129(6):1397-1410.
80. Gerety S.S., Wang H.U., et al. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell. 1999, 4(3):403-414.
81. Gerhardt H., Golding M., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell. Biol. 2003, 161(6):1163-1177.
82. Gerhardt H., Ruhrberg C., et al. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn. 2004, 231(3):503-509.
83. Giger R.J., Cloutier J.F., et al. Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron 2000, 25(1):29-41.
84. Gitler A.D., Lu M.M., et al. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev. Cell. 2004, 7(1):107-116.
85. Goishi K., Klagsbrun M. Vascular endothelial growth factor and its receptors in embryonic zebrafish blood vessel development. Curr. Top. Dev. Biol. 2004, 62:127-152.
86. Gore A.V., Swift M.R., et al. Rspo1/Wnt signaling promotes angiogenesis via Vegfc/Vegfr3. Development 2011, 138(22):4875-4886.
87. Gridley T. Notch signaling and inherited disease syndromes. Hum. Mol. Genet 2003, 1(12 Spec No 1):R9-13.
88. Grunewald M., Avraham I., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124(1):175-189.
89. Gu C., Rodriguez E.R., et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell. 2003, 5(1):45-57.
90. Gu C., Yoshida Y., et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005, 307(5707):265-268.
91. Hagerling R., Pollmann C., et al. A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO. J. 2013, 32(5):629-644.
92. Hedgecock E.M., Culotti J.G., et al. The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans. Neuron 1990, 4(1):61-85.
93. Herbert S.P., Huisken J., et al. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation. Science 2009, 326(5950):294-298.
94. Herbert S.P., Stainier D.Y. Molecular control of endothelial cell behavior during blood vessel morphogenesis. Nat. Rev. Mol. Cell. Biol. 2011, 12(9):551-564.
95. Hermans K., Claes F., et al. Role of synectin in lymphatic development in zebrafish and frogs. Blood 2010, 116(17):3356-3366.
96. Herzog Y., Kalcheim C., et al. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev. 2001, 109(1):115-119.
97. Hirschi K.K. Hemogenic endothelium during development and beyond. Blood 2012, 119(21):4823-4827.
98. His W., et al. Lecithoblast und Angioblast der Wirbeltiere. Abh. Math-Phys. Kl. Saechs. Ges. 1900, 26:171-328.
99. Hogan K.A., Ambler C.A., et al. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development 2004, 131(7):1503-1513.
100. Hong Y.K., Harvey N., et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn. 2002, 225(3):351-357.
101. Huber T.L., Kouskoff V., et al. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 2004, 432(7017):625-630.
102. Huminiecki L., Gorn M., et al. Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis. Genomics 2002, 79(4):547-552.
103. Huntington G., McClure C. The anatomy and development of the jugular lymph sac in the domestic cat (Felis domestica). Am. J. Anat. 1910, 10:177-311.
104. Ichise H., Ichise T., et al. Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 2009, 136(2):191-195.
105. Ilan N., Mahooti S., et al. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell. Sci. 1998, 111(Pt 24):3621-3631.
106. Irrthum A., Devriendt K., et al. Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am. J. Hum. Genet. 2003, 72(6):1470-1478.
107. Ishii N., Wadsworth W.G., et al. UNC-6, a laminin-related protein, guides cell and pioneer axon migrations in C. elegans. Neuron 1992, 9(5):873-881.
108. Isogai S., Horiguchi M., et al. The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev. Biol. 2001, 230(2):278-301.
109. Isogai S., Lawson N.D., et al. Angiogenic network formation in the developing vertebrate trunk. Development 2003, 130(21):5281-5290.
110. Jaffredo T., Bollerot K., et al. Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cells. Int. J. Dev. Biol. 2005, 49(2-3):269-277.
111. Jaffredo T., Nottingham W., et al. From hemangioblast to hematopoietic stem cell: an endothelial connection?. Exp. Hematol. 2005, 33(9):1029-1040.
112. Jakeman L.B., Armanini M., et al. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993, 133(2):848-859.
113. Jakobsson L., Franco C.A., et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell. Biol. 2010, 12(10):943-953.
114. Jiang Y.J., Brand M., et al. Mutations affecting neurogenesis and brain morphology in the zebrafish, Danio rerio. Development 1996, 123:205-216.
115. Johnson N.C., Dillard M.E., et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes. Dev. 2008, 22(23):3282-3291.
116. Jones C.A., London N.R., et al. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 2008, 14(4):448-453.
117. Jones C.A., Nishiya N., et al. Slit2-Robo4 signaling promotes vascular stability by blocking Arf6 activity. Nat. Cell. Biol. 2009, 11(11):1325-1331.
118. Kaipainen A., Korhonen J., et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. Natl. Acad. Sci. USA 1995, 92(8):3566-3570.
119. Kalimo H., Ruchoux M.M., et al. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain. Pathol. 2002, 12(3):371-384.
120. Kallianpur A.R., Jordan J.E., et al. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 1994, 83(5):1200-1208.
121. Kamath B.M., Spinner N.B., et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 2004, 109(11):1354-1358.
122. Kamei M., Saunders W.B., et al. Endothelial tubes assemble from intracellular vacuoles in vivo. Nature 2006, 442(7101):453-456.
123. Kappas N.C., Zeng G., et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell. Biol. 2008, 181(5):847-858.
124. Karkkainen M.J., Haiko P., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5(1):74-80.
125. Karkkainen M.J., Saaristo A., et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 2001, 98(22):12677-12682.
126. Kawai-Kowase K., Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell. Physiol. 2007, 292(1):C59-C69.
127. Kawasaki T., Kitsukawa T., et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999, 126(21):4895-4902.
128. Kearney J.B., Ambler C.A., et al. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 2002, 99(7):2397-2407.
129. Keino-Masu K., Masu M., et al. Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 1996, 87(2):175-185.
130. Kim H., Nguyen V.P., et al. Embryonic vascular endothelial cells are malleable to reprogramming via Prox1 to a lymphatic gene signature. BMC. Dev. Biol. 2010, 10:72.
131. Kinder S.J., Loebel D.A., et al. Allocation and early differentiation of cardiovascular progenitors in the mouse embryo. Trends. Cardiovasc. Med. 2001, 11(5):177-184.
132. Klagsbrun M., D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine. Growth. Factor. Rev. 1996, 7(3):259-270.
133. Klein R. Eph/ephrin signaling during development. Development 2012, 139(22):4105-4109.
134. Klessinger S., Christ B. Axial structures control laterality in the distribution pattern of endothelial cells. Anat. Embryol. (Berl.) 1996, 193(4):319-330.
135. Koch A.W., Mathivet T., et al. Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev. Cell. 2011, 20(1):33-46.
136. Koshiba-Takeuchi K., Mori A.D., et al. Reptilian heart development and the molecular basis of cardiac chamber evolution. Nature 2009, 461(7260):95-98.
137. Krebs L.T., Xue Y., et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000, 14(11):1343-1352.
138. Kuchler A.M., Gjini E., et al. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr. Biol. 2006, 16(12):1244-1248.
139. Kukk E., Lymboussaki A., et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996, 122(12):3829-3837.
140. Kullander K., Klein R. Mechanisms and functions of Eph and ephrin signaling. Nat. Rev. Mol. Cell. Biol. 2002, 3(7):475-486.
141. Lamont R.E., Lamont E.J., et al. Antagonistic interactions among Plexins regulate the timing of intersegmental vessel formation. Dev. Biol. 2009, 331(2):199-209.
142. Larrivee B., Freitas C., et al. Guidance of vascular development: lessons from the nervous system. Circ. Res. 2009, 104(4):428-441.
143. Larrivee B., Freitas C., et al. Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes. Dev. 2007, 21(19):2433-2447.
144. Lawson N.D., Scheer N., et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001, 128(19):3675-3683.
145. Lawson N.D., Vogel A.M., et al. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev. Cell. 2002, 3(1):127-136.
146. Lawson N.D., Weinstein B.M. Arteries and veins: making a difference with zebrafish. Nat. Rev. Genet. 2002, 3(9):674-682.
147. le Noble F., Moyon D., et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 2004, 131(2):361-375.
148. Lee P., Goishi K., et al. Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc. Natl. Acad. Sci. USA 2002, 99(16):10470-10475.
149. Lee S., Kang J., et al. Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 2009, 113(8):1856-1859.
150. Lejmi E., Leconte L., et al. Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of Unc5B. Proc. Natl. Acad. Sci. USA 2008, 105(34):12491-12496.
151. Leonardo E.D., Hinck L., et al. Guidance of developing axons by netrin-1 and its receptors. Cold. Spring. Harb. Symp. Quant. Biol. 1997, 62:467-478.
152. Leu A.J., Berk D.A., et al. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer. Res. 2000, 60(16):4324-4327.
153. Liang D., Chang J.R., et al. The role of vascular endothelial growth factor (VEGF) in vasculogenesis, angiogenesis, and hematopoiesis in zebrafish development. Mech. Dev. 2001, 108(1-2):29-43.
154. Liang D., Xu X., et al. Cloning and characterization of vascular endothelial growth factor (VEGF) from zebrafish, Danio rerio. Biochim. Biophys. Acta. 1998, 1397(1):14-20.
155. Liao W., Bisgrove B.W., et al. The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development 1997, 124(2):381-389.
156. Lim A.H., Suli A., et al. Motoneurons are essential for vascular pathfinding. Development 2011, 138(17):3847-3857.
157. Limaye N., Wouters V., et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat. Genet. 2009, 41(1):118-124.
158. Long H., Sabatier C., et al. Conserved roles for Slit and Robo proteins in midline commissural axon guidance. Neuron 2004, 42(2):213-223.
159. Lu X., Le Noble F., et al. The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature 2004, 432(7014):179-186.
160. Maisonpierre P.C., Suri C., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277(5322):55-60.
161. Makinen T., Adams R.H., et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes. Dev. 2005, 19(3):397-410.
162. Makinen T., Jussila L., et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 2001, 7(2):199-205.
163. Mandriota S.J., Jussila L., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis. EMBO. J. 2001, 20(4):672-682.
164. Marlow R., Binnewies M., et al. Vascular Robo4 restricts proangiogenic VEGF signaling in breast. Proc. Natl. Acad. Sci. USA 2010, 107(23):10520-10525.
165. Marron M.B., Hughes D.P., et al. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. J. Biol. Chem. 2000, 275(50):39741-39746.
166. Martyn U., Schulte-Merker S. Zebrafish neuropilins are differentially expressed and interact with vascular endothelial growth factor during embryonic vascular development. Dev. Dyn. 2004, 231(1):33-42.
167. Meadows S.M., Fletcher P.J., et al. Integration of repulsive guidance cues generates avascular zones that shape mammalian blood vessels. Circ. Res. 2012, 110(1):34-46.
168. Melani M., Weinstein B.M. Common factors regulating patterning of the nervous and vascular systems. Annu. Rev. Cell. Dev. Biol. 2010, 26:639-665.
169. Miao H.Q., Soker S., et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell. Biol. 1999, 146(1):233-242.
170. Mishima K., Watabe T., et al. Prox1 induces lymphatic endothelial differentiation via integrin alpha9 and other signaling cascades. Mol. Biol. Cell. 2007, 18(4):1421-1429.
171. Moyon D., Pardanaud L., et al. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 2001, 128(17):3359-3370.
172. Moyon D., Pardanaud L., et al. Selective expression of angiopoietin 1 and 2 in mesenchymal cells surrounding veins and arteries of the avian embryo. Mech. Dev. 2001, 106(1-2):133-136.
173. Murray P.D.F. The development in vitro of the blood of the early chick embryo. Proc. R. Soc. B London, Ser. B 1932, 111:497-521.
174. Nakagawa O., McFadden D.G., et al. Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling. Proc. Natl. Acad. Sci. USA 2000, 97(25):13655-13660.
175. Nakagawa O., Nakagawa M., et al. HRT1, HRT2, and HRT3: a new subclass of bHLH transcription factors marking specific cardiac, somitic, and pharyngeal arch segments. Dev. Biol. 1999, 216(1):72-84.
176. Nakayama M., Berger P. Coordination of VEGF receptor trafficking and signaling by coreceptors. Exp. Cell. Res. 2013, 319(9):1340-1347.
177. Navankasattusas S., Whitehead K.J., et al. The netrin receptor UNC5B promotes angiogenesis in specific vascular beds. Development 2008, 135(4):659-667.
178. Nikolova G., Lammert E. Interdependent development of blood vessels and organs. Cell. Tissue. Res. 2003, 314(1):33-42.
179. Ny A., Koch M., et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 2005, 11(9):998-1004.
180. Oh S.J., Jeltsch M.M., et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev. Biol. 1997, 188(1):96-109.
181. Oliver G. Lymphatic vasculature development. Nat. Rev. Immunol. 2004, 4(1):35-45.
182. Orlandi A., Bennett M. Progenitor cell-derived smooth muscle cells in vascular disease. Biochem. Pharmacol. 2010, 79(12):1706-1713.
183. Osada M., Inoue O., et al. Platelet activation receptor CLEC-2 regulates blood/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells. J. Biol. Chem. 2012, 287(26):22241-22252.
184. Othman-Hassan K., Patel K., et al. Arterial identity of endothelial cells is controlled by local cues. Dev. Biol. 2001, 237(2):398-409.
185. Owens G.K., Kumar M.S., et al. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84(3):767-801.
186. Pan W., Pham V.N., et al. CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis. Blood 2012, 120(2):489-498.
187. Pardanaud L., Dieterlen-Lievre F. Manipulation of the angiopoietic/hemangiopoietic commitment in the avian embryo. Development 1999, 126(4):617-627.
188. Park K.W., Crouse D., et al. The axonal attractant Netrin-1 is an angiogenic factor. Proc. Natl. Acad. Sci. USA 2004, 101(46):16210-16215.
189. Park K.W., Morrison C.M., et al. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev. Biol. 2003, 261(1):251-267.
190. Partanen T.A., Vuola P., et al. Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations. Angiogenesis 2013, 16(1):137-146.
191. Petrova T.V., Makinen T., et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO. J. 2002, 21(17):4593-4599.
192. Pitulescu M.E., Adams R.H. Eph/ephrin molecules - a hub for signaling and endocytosis. Genes. Dev. 2010, 24(22):2480-2492.
193. Pola R., Ling L.E., et al. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat. Med. 2001, 7(6):706-711.
194. Puri M.C., Rossant J., et al. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO. J. 1995, 14(23):5884-5891.
195. Raimondi C., Ruhrberg C. Neuropilin signaling in vessels, neurons and tumors. Semin. Cell. Dev. Biol. 2013, 24(3):172-178.
196. Reese D.E., Hall C.E., et al. Negative regulation of midline vascular development by the notochord. Dev. Cell. 2004, 6(5):699-708.
197. Risau W. Mechanisms of angiogenesis. Nature 1997, 386(6626):671-674.
198. Risau W., Flamme I. Vasculogenesis. Annu. Rev. Cell. Dev. Biol. 1995, 11:73-91.
199. Rossant J., Hirashima M. Vascular development and patterning: making the right choices. Curr. Opin. Genet. Dev. 2003, 13(4):408-412.
200. Rossant J., Howard L. Signaling pathways in vascular development. Annu. Rev. Cell. Dev. Biol. 2002, 18:541-573.
201. Ruchoux M.M., Chabriat H., et al. Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke 1994, 25(11):2291-2292.
202. Ruchoux M.M., Domenga V., et al. Transgenic mice expression mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol 2003, 162(1):329-342.
203. Sabin F.R. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am. J. Anat. 1902, 1:367-389.
204. Saharinen P., Kerkela K., et al. Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J. Cell. Biol. 2005, 169(2):239-243.
205. Sakata Y., Kamei C.N., et al. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc. Natl. Acad. Sci. USA 2002, 99(25):16197-16202.
206. Sato T.N., Qin Y., et al. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc. Natl. Acad. Sci. USA 1993, 90(20):9355-9358.
207. Sato T.N., Tozawa Y., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376(6535):70-74.
208. Scappaticci F.A. Mechanisms and future directions for angiogenesis-based cancer therapies. J. Clin. Oncol. 2002, 20(18):3906-3927.
209. Schacht V., Ramirez M.I., et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO. J. 2003, 22(14):3546-3556.
210. Schröder J.M., Sellhaus B., et al. Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol 1995, 89(2):116-121.
211. Schulte-Merker S., van Eeden F.J., et al. no tail (ntl) is the zebrafish homologue of the mouse T (Brachyury) gene. Development 1994, 120(4):1009-1015.
212. Sebzda E., Hibbard C., et al. Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev. Cell. 2006, 11(3):349-361.
213. Segarra M., Ohnuki H., et al. Semaphorin 6A regulates angiogenesis by modulating VEGF signaling. Blood 2012, 120(19):4104-4115.
214. Serafini T., Colamarino S.A., et al. Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system. Cell 1996, 87(6):1001-1014.
215. Serafini T., Kennedy T.E., et al. The netrins define a family of axon outgrowth-promoting proteins homologous to C. elegans UNC-6. Cell 1994, 78(3):409-424.
216. Shalaby F., Rossant J., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376(6535):62-66.
217. Shin J.W., Min M., et al. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol. Biol. Cell. 2006, 17(2):576-584.
218. Shirayoshi Y., Yuasa Y., et al. Proto-oncogene of int-3, a mouse Notch homologue, is expressed in endothelial cells during early embryogenesis. Genes. Cells. 1997, 2(3):213-224.
219. Shivdasani R.A., Mayer E.L., et al. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature 1995, 373(6513):432-434.
220. Shutter J.R., Scully S., et al. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes Dev. 2000, 14(11):1313-1318.
221. Shweiki D., Itin A., et al. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J. Clin. Invest. 1993, 91(5):2235-2243.
222. Simons M. An inside view: VEGF receptor trafficking and signaling. Physiol. (Bethesda) 2012, 27(4):213-222.
223. Skobe M., Hawighorst T., et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat. Med. 2001, 7(2):192-198.
224. Small E.M., Sutherland L.B., et al. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ. Res. 2010, 107(11):1336-1344.
225. Soker S., Takashima S., et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92(6):735-745.
226. Srinivasan R.S., Dillard M.E., et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes. Dev. 2007, 21(19):2422-2432.
227. Srinivasan R.S., Geng X., et al. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev. 2010, 24(7):696-707.
228. Stacker S.A., Caesar C., et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat. Med. 2001, 7(2):186-191.
229. Stainier D.Y., Weinstein B.M., et al. Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 1995, 121(10):3141-3150.
230. Stratman A.N., Davis G.E. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc. Microanal. 2012, 18(1):68-80.
231. Stratman A.N., Davis M.J., et al. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 2011, 117(14):3709-3719.
232. Suchting S., Heal P., et al. Soluble Robo4 receptor inhibits in vivo angiogenesis and endothelial cell migration. FASEB. J. 2005, 19(1):121-123.
233. Sumoy L., Keasey J.B., et al. A role for notochord in axial vascular development revealed by analysis of phenotype and the expression of VEGR-2 in zebrafish flh and ntl mutant embryos. Mech. Dev. 1997, 63(1):15-27.
234. Suri C., Jones P.F., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87(7):1171-1180.
235. Suri C., McClain J., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282(5388):468-471.
236. Suzuki-Inoue K., Fuller G.L., et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006, 107(2):542-549.
237. Suzuki-Inoue K., Kato Y., et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J. Biol. Chem. 2007, 282(36):25993-26001.
238. Swiatek P.J., Lindsell C.E., et al. Notch1 is essential for postimplantation development in mice. Genes. Dev. 1994, 8(6):707-719.
239. Takakura N., Huang X.L., et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity 1998, 9(5):677-686.
240. Takashima S., Kitakaze M., et al. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 2002, 99(6):3657-3662.
241. Talbot W.S., Trevarrow B., et al. A homeobox gene essential for zebrafish notochord development. Nature 1995, 378(6553):150-157.
242. Tammela T., Zarkada G., et al. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signaling. Nat. Cell. Biol. 2011, 13(10):1202-1213.
243. Thompson M.A., Ransom D.G., et al. The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. Dev. Biol. 1998, 197(2):248-269.
244. Thurston G., Wang Q., et al. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 2005, 132(14):3317-3326.
245. Torres-Vazquez J., Gitler A.D., et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev. Cell. 2004, 7(1):117-123.
246. Torres-Vazquez J., Kamei M., et al. Molecular distinction between arteries and veins. Cell. Tissue. Res. 2003, 314(1):43-59.
247. Tsiamis A.C., Morris P.N., et al. Vascular endothelial growth factor modulates the Tie-2:Tie-1 receptor complex. Microvasc. Res. 2002, 63(2):149-158.
248. Uhrin P., Zaujec J., et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010, 115(19):3997-4005.
249. Uyttendaele H., Ho J., et al. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc. Natl. Acad. Sci. USA 2001, 98(10):5643-5648.
250. Vajkoczy P., Menger M.D., et al. Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1999, 1(1):31-41.
251. Vargesson N., Patel K., et al. Expression patterns of Notch1, Serrate1, Serrate2 and Delta1 in tissues of the developing chick limb. Mech. Dev. 1998, 77(2):197-199.
252. Vikkula M., Boon L.M., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996, 87(7):1181-1190.
253. Villa N., Walker L., et al. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 2001, 108(1-2):161-164.
254. Visvader J.E., Fujiwara Y., et al. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes. Dev. 1998, 12(4):473-479.
255. Vittet D., Prandini M.H., et al. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 1996, 88(9):3424-3431.
256. Vokes S.A., Yatskievych T.A., et al. Hedgehog signaling is essential for endothelial tube formation during vasculogenesis. Development 2004, 131(17):4371-4380.
257. Wacker A., Gerhardt H. Endothelial development taking shape. Curr. Opin. Cell. Biol. 2011, 23(6):676-685.
258. Wang B., Xiao Y., et al. Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell. 2003, 4(1):19-29.
259. Wang H.U., Chen Z.F., et al. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998, 93(5):741-753.
260. Wang R., Clark R., et al. Embryonic stem cell-derived cystic embryoid bodies form vascular channels: an in vitro model of blood vessel development. Development 1992, 114(2):303-316.
261. Wang Y., Nakayama M., et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 2010, 465(7297):483-486.
262. Weinstein B.M. Plumbing the mysteries of vascular development using the zebrafish. Semin. Cell. Dev. Biol. 2002, 13(6):515-522.
263. Wettstein D.A., Turner D.L., et al. The Xenopus homolog of Drosophila Suppressor of Hairless mediates Notch signaling during primary neurogenesis. Development 1997, 124(3):693-702.
264. Wigle J.T., Harvey N., et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO. J. 2002, 21(7):1505-1513.
265. Wigle J.T., Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999, 98(6):769-778.
266. Wiles M.V., Keller G. Multiple hematopoietic lineages develop from embryonic stem (ES) cells in culture. Development 1991, 111(2):259-267.
267. Willett C.G., Boucher Y., et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 2004, 10(2):145-147.
268. Williams C., Kim S.H., et al. Hedgehog signaling induces arterial endothelial cell formation by repressing venous cell fate. Dev. Biol. 2010, 341(1):196-204.
269. Williams N., Burgess A.W. The effect of mouse lung granulocyte-macrophage colony-stimulating factor and other colony-stimulating activities on the proliferation and differentiation of murine bone marrow cells in long-term cultures. J. Cell. Physiol. 1980, 102(3):287-295.
270. Wilson B.D., Ii M., et al. Netrins promote developmental and therapeutic angiogenesis. Science 2006, 313(5787):640-644.
271. Wilting J., Aref Y., et al. Dual origin of avian lymphatics. Dev. Biol. 2006, 292(1):165-173.
272. Wilting J., Papoutsi M., et al. The lymphatic endothelium of the avian wing is of somitic origin. Dev. Dyn. 2000, 217(3):271-278.
273. Witte M.H., Bernas M.J., et al. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc. Res. Tech. 2001, 55(2):122-145.
274. Wouters V., Limaye N., et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur. J. Hum. Genet. 2010, 18(4):414-420.
275. Xue Y., Gao X., et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum. Mol. Genet. 1999, 8(5):723-730.
276. Yamazaki T., Yoshimatsu Y., et al. COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 2009, 14(3):425-434.
277. Yancopoulos G.D., Davis S., et al. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407(6801):242-248.
278. Yancopoulos G.D., Klagsbrun M., et al. Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border. Cell 1998, 93(5):661-664.
279. Yang Y., Garcia-Verdugo J.M., et al. Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos. Blood 2012, 120(11):2340-2348.
280. Yaniv K., Isogai S., et al. Live imaging of lymphatic development in the zebrafish. Nat. Med. 2006, 12(6):711-716.
281. Yu H.H., Houart C., et al. Cloning and embryonic expression of zebrafish neuropilin genes. Gene. Expr. Patterns 2004, 4(4):371-378.
282. Yuan L., Moyon D., et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002, 129(20):4797-4806.
283. Zape J.P., Zovein A.C. Hemogenic endothelium: origins, regulation, and implications for vascular biology. Semin. Cell. Dev. Biol. 2011, 22(9):1036-1047.
284. Zhang Y., Singh M.K., et al. Tie2Cre-mediated inactivation of plexinD1 results in congenital heart, vascular and skeletal defects. Dev. Biol. 2009, 325(1):82-93.
285. Zhong T.P., Childs S., et al. Gridlock signaling pathway fashions the first embryonic artery. Nature 2001, 414(6860):216-220.
286. Zhong T.P., Rosenberg M., et al. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 2000, 287(5459):1820-1824.
287. Zovein A.C., Hofmann J.J., et al. Fate tracing reveals the endothelial origin of hematopoietic stem cells. Cell. Stem. Cell. 2008, 3(6):625-636.
288. Zygmunt T., Gay C.M., et al. Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1. Dev. Cell. 2011, 21(2):301-314.